Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — Tangible Net Worth Ratio
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Tangible Net Worth Ratio of 99.7% as of March 2026. This metric is calculated by deducting intangible assets (CN¥4.05 Million) from net assets (CN¥1.27 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 688621 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Beijing Sun Novo Pharmaceutical Research Co Ltd Tangible Net Worth Ratio (2017–2025)
This chart shows how Beijing Sun Novo Pharmaceutical Research Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 99.7%, reflecting net assets of CN¥1.27 Billion with intangible assets of CN¥4.05 Million CNY. For live market cap and overall valuation, see how much is Beijing Sun Novo Pharmaceutical Research worth.
Annual Tangible Net Worth Ratio for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Beijing Sun Novo Pharmaceutical Research Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of Beijing Sun Novo Pharmaceutical Research to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.6% | CN¥1.23 Billion | CN¥4.73 Million | CN¥2.28 Billion | ▲ +0.1 pp |
| 2024 | 99.5% | CN¥1.10 Billion | CN¥5.41 Million | CN¥1.99 Billion | ▲ +0.0 pp |
| 2023 | 99.5% | CN¥1.06 Billion | CN¥5.39 Million | CN¥1.86 Billion | ▼ 0.0 pp |
| 2022 | 99.5% | CN¥908.23 Million | CN¥4.20 Million | CN¥1.46 Billion | ▼ 0.0 pp |
| 2021 | 99.6% | CN¥769.64 Million | CN¥3.32 Million | CN¥1.24 Billion | ▲ +1.7 pp |
| 2020 | 97.9% | CN¥192.92 Million | CN¥4.04 Million | CN¥384.86 Million | ▲ +1.3 pp |
| 2019 | 96.6% | CN¥118.76 Million | CN¥4.06 Million | CN¥285.51 Million | ▼ -1.1 pp |
| 2018 | 97.7% | CN¥73.82 Million | CN¥1.69 Million | CN¥201.50 Million | ▲ +2.9 pp |
| 2017 | 94.8% | CN¥33.25 Million | CN¥1.72 Million | CN¥110.07 Million | — |